| Ytd | -83.10% | |
| 1y | -96.56% |
| Open | 5.21 | Prev Close | 5.12 | Low | 4.93 | High | 5.21 | Mkt Cap | 18.96M |
| Vol | 23.96K | Avg Vol | 94.85K | EPS | -12.56 | P/E | N/A | Forward P/E | N/A |
| Beta | -0.42 | Short Ratio | 0.08 | Inst. Own | 37.09% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 4.65 | 200-d Avg | 6.43 | 1yr Est | 0.00 |
Benuvia operates an 83,000-square-foot, DEA-registered controlled-substance manufacturing facility i
Partnership intended to establish a Texas-based manufacturing pathway for pharmaceutical-grade iboga
The term sheet is binding on the parties and is to be superseded by a definitive agreement, which th
Transactions include an investment of up to US$5 million in PsyLabs and an approximately US$9 millio
Gainers Amylyx Pharmaceuticals (NASDAQ:AMLX) stock increased by 27.5% to $27.32 during Tuesday'
Psyence BioMed Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a biopharmaceu
LaCorium AcquisitionThe Company today is also announcing a definitive agreement to acquire LaCorium
https://www.hhs.gov/press-room/fda-accelerates-action-treatments-serious-mental-illness-following-ex
Psyence Biomedical faces a double-digit decline Tuesday as traders lock in gains following a massive
Psyence Biomedical stock faces profit-taking on Tuesday after a massive rally fueled by a Trump exec
Psyence Biomedical (NASDAQ: PBM) stock is surging Monday on a broad psychedelic rally and a company-
Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a clinical
TopBuild Corp (NYSE: BLD) rises in pre-market trading after QXO (NYSE: QXO) agrees to acquire for $1
US stocks rise, Dow gains 600 points. NASDAQ up 1.05% and S&P 500 up 0.74%. Energy stocks down 4
Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a clinical
Blaize Holdings rose 24.3% in pre-market trading on $50M contract with NeoTensr & MOU with Winma
https://www.cbsnews.com/news/psychedelic-drug-ibogaine-ptsd-trump-to-sign-executive-order/
syence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a biopharma
Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a biopharm